4//SEC Filing
MNAYMNEH SAMI 4
Accession 0000899243-19-024078
CIK 0001274737other
Filed
Sep 22, 8:00 PM ET
Accepted
Sep 23, 9:43 PM ET
Size
14.4 KB
Accession
0000899243-19-024078
Insider Transaction Report
Form 4
EXAGEN INC.XGN
H.I.G. Bio-Exagen, L.P.
10% Owner
Transactions
- Purchase
Common Stock
2019-09-23$14.00/sh+425,000$5,950,000→ 1,696,252 total(indirect: See footnote) - Conversion
Common Stock
2019-09-23+1,271,252→ 1,271,252 total(indirect: See footnote) - Conversion
Series H Redeemable Convertible Preferred Stock
2019-09-23−233,446,519→ 0 total(indirect: See footnote)→ Common Stock (1,271,252 underlying)
H.I.G.-GPII, Inc.
10% Owner
Transactions
- Purchase
Common Stock
2019-09-23$14.00/sh+425,000$5,950,000→ 1,696,252 total(indirect: See footnote) - Conversion
Series H Redeemable Convertible Preferred Stock
2019-09-23−233,446,519→ 0 total(indirect: See footnote)→ Common Stock (1,271,252 underlying) - Conversion
Common Stock
2019-09-23+1,271,252→ 1,271,252 total(indirect: See footnote)
TAMER ANTHONY
10% Owner
Transactions
- Conversion
Common Stock
2019-09-23+1,271,252→ 1,271,252 total(indirect: See footnote) - Purchase
Common Stock
2019-09-23$14.00/sh+425,000$5,950,000→ 1,696,252 total(indirect: See footnote) - Conversion
Series H Redeemable Convertible Preferred Stock
2019-09-23−233,446,519→ 0 total(indirect: See footnote)→ Common Stock (1,271,252 underlying)
MNAYMNEH SAMI
10% Owner
Transactions
- Conversion
Common Stock
2019-09-23+1,271,252→ 1,271,252 total(indirect: See footnote) - Conversion
Series H Redeemable Convertible Preferred Stock
2019-09-23−233,446,519→ 0 total(indirect: See footnote)→ Common Stock (1,271,252 underlying) - Purchase
Common Stock
2019-09-23$14.00/sh+425,000$5,950,000→ 1,696,252 total(indirect: See footnote)
Footnotes (2)
- [F1]The shares reported on this form are held of record by H.I.G. Bio-Exagen, L.P. ("H.I.G."). H.I.G.-GPII, Inc. ("H.I.G. GP") is the general partner of H.I.G. and has sole voting and investment control over the shares owned by H.I.G. Anthony Tamer and Sami Mnaymneh are the sole shareholders of H.I.G. GP and may be deemed to share beneficial ownership of the shares held by H.I.G. Bio-Exagen, L.P. Each of Mr. Tamer and Mr. Mnaymneh disclaims beneficial ownership of the shares reported herein except to the extent of their pecuniary interest, if any.
- [F2]The Series H Redeemable Convertible Preferred Stock ("Series H") is convertible into the Issuer's Common Stock on a 183.635-for-one basis at the holder's election and has no expiration date. The Series H automatically converted into Common Stock upon the closing of the Issuer's initial public offering.
Documents
Issuer
EXAGEN INC.
CIK 0001274737
Entity typeother
Related Parties
1- filerCIK 0001050046
Filing Metadata
- Form type
- 4
- Filed
- Sep 22, 8:00 PM ET
- Accepted
- Sep 23, 9:43 PM ET
- Size
- 14.4 KB